Mediquip Corp. produces surgical instruments to support heart surgeons ("Mediquip"). Historically. the company has raised capital by selling its debt instruments to investors on a private basis. It has just recently sold a new offering of debt to investors by registering it with the Securities and Exchange Commission. Assuming its credit ratings and credit ratings outlook and market interest rates have not changed since it raised debt farlier, would Mediquip expect to see any change in the interest rate on its new debt (versus its previous debt)? No, because the company's credit ratings have not changed and market interest rates have not changed. Yes, the rate should be lower on the new debt offering because more investors will be able to bid on the purchase. No, because the normally higher interest rate required by a new offering would be offset by the wider circle of prospective investors. Yes, the rate should be higher because its previous debt offerings outstanding will be more attractive to investors versus the new offering